English

Español

Pусский

Français

Deutsch

简体中文

Old Website
Total PCR Solution
About Us
  • Who We Are
  • What We Do
  • Our History
  • R&D Capabilities
Product Center
  • System
    • Nucleic Acid Extraction Solution
    • Workstation
    • Real-time PCR System
  • Assay
    • Respiratory Infectious Diseases
    • Cervical Cancer Screening
    • Sexually Transmitted Diseases
    • Vector-Borne Diseases
    • Gastrointestinal Infectious Diseases
    • Zoonotic Infectious Diseases
    • Life Science
Media Center
  • News
  • Events
Service Network
  • Service Offering
  • e-Support
Careers
Contact Us
News Center
to grab latest progress of the company and industry
BioPerfectus Received Export Commodity Brand Certificate from the CCPIT

BioPerfectus was recently certified as the Export Commodity Brand by the CCPIT (China Council for the Promotion of International Trade). The quality of BioPerfectus Molecular diagnostic products has been officially recognized by the CCPIT.

2023-02-02 Read more
Four New Arrivals for Better Confronting Sexually Transmitted Diseases and Respiratory Infectious Diseases

BioPerfectus is proud to launch four new PCR products: Mycoplasma Genitalium Real Time PCR Kit, Herpes Simplex Virus Real Time PCR Kit, Trichomonas Vaginalis Real Time PCR Kit and Respiratory Virus Panel (7) Real Time PCR Kit.

2023-01-31 Read more
Announcing BioPerfectus New Brand Identity

BioPerfectus will start the next "golden decade" with a new attitude and adopt a more international logo in a broader commercial market. We aim to create a stronger image that would build on the previous one and accurately describe who we are today: one of the global IVD suppliers with a mission to embrace the world with health.

2022-12-26 Read more
Bioperfectus and World Health Organization (WHO) Collaborate on Molecular Diagnostics

A batch of Bioperfectus-developed Nucleic Acid Extraction System SSNP-2000B began shipping today to World Health Organization (WHO). The distribution of Bioperfectus SSNP-2000B Nucleic Acid Extraction System will support the development of molecular diagnostics in Africa.

2022-10-25 Read more
Bioperfectus Supports Cholera Elimination

SHANGHAI, CHINA, December 5, 2022—Jiangsu Bioperfectus Technologies Co., Ltd. (hereinafter referred to as “Bioperfectus”) is pleased to launch Vibrio Cholerae Real Time PCR Kits for human diagnosis and early warning surveillance.

2022-11-30 Read more
Client Story: A Race Against Time

Through a critical assessment of clinical evaluation and data validation, Bioperfetus successfully passed the Israeli ministry of health inspection. Bioperfetus was the only Chinese company on the procurement list and was asked to provide one million antigen rapid test kits for the Israeli ministry of health.

2022-11-15 Read more
Bioperfectus Granted MDA Approval in Malaysia for Nucleic Acid Extraction Systems

SHANGHAI, CHINA, November 14, 2022—Jiangsu Bioperfectus Technologies Co., Ltd. (hereinafter referred to as “Bioperfectus”), a leading global company in the molecular diagnostics market, today announced receipt of MDA (Medical Device Authority) approval in Malaysia for Nucleic Acid Extraction Systems, including Nucleic Acid SSNP-2000B, SSNP-3000A, SSNP-9600A, SMPE-960 and Extraction Rapid Kit (Magnetic Bead Method).

2022-11-14 Read more
Clinical Validation of Bioperfectus Monkeypox Virus (MPXV) Fast Real Time PCR Kit

Jiangsu BioPerfectus Technologies Co., Ltd. (hereinafter referred to as “Bioperfectus”) applied for the clinical evaluation in XYZ Laboratory (XYZ Laboratory 2009 Ranch Rd. 620 N, STE 325, Austin, TX 78732, USA), a CAP accredited CLIA certified high complexity clinical molecular diagnostic laboratory to perform and report the Bioperfectus Monkeypox Virus (MPXV) Fast Real Time PCR Kit.

2022-11-07 Read more
The COVID-19 is Delaying the Cervical Cancer Screening

Human papillomavirus (HPV) is the primary cause of cervical cancer, which is preventable through screening and early treatment. The elimination of cervical cancer has been defined by the WHO as achieving an incidence rate below 4 cases per 100,000 women per year since 2020.

2022-10-25 Read more
Bioperfectus Emergency Response Training for Ebola Virus Diagnostics and Testing

Bioperfectus conducted emergency training to assist frontline healthcare professionals in Uganda using Real-Time PCR diagnostic tools for early detection and control of the latest Ebola outbreak.

2022-10-19 Read more
HomePrev12345678910...NextEnd
  • About Us
  • Who We Are
  • What We Do
  • Our History
  • R&D Capabilities
  • Product Center
  • System
  • Assay
  • Media Center
  • News
  • Events
  • Service Network
  • Service Offering
  • e-Support
  • Careers
  • Contact Us
  • Total PCR Solution
Follow Us

Copyright © 2010-2022 Jiangsu Bioperfectus Technologies Co., Ltd All Rights Reserved.

Tel: +86 021-5484 7326 Email: info@bioperfectus.com